Myocardial oxidative stress protection by sevoflurane vs. propofol: A Randomised controlled study in patients undergoing off-pump coronary artery bypass graft surgery

European Journal of Anaesthesiology

Volumn 28, Issue 12, 2011, Pages 874-881

  Ballester, Mayte ^a   Llorens, Julio ^a   Garcia De La Asuncion, Jose ^a   Perez Griera, Jaime ^b   Tebar, Eduardo ^c,e   Martinez Leon, Juan ^c,d   Belda, Javier ^a   Juez, Marina ^c  

^a HOSPITAL CLÍNICO UNIVERSITARIO   (Spain)

^b Biochemical Laboratory   (Spain)

^c Department of Cardiovascular Surgery ^*  (Spain)

^d HOSPITAL GENERAL UNIVERSITARIO DE ALICANTE   (Spain)

^e Valencia and Hospital de Vinalopo   (Spain)

Author keywords

Anaesthetics; Cardioprotection; Cardiovascular; Inflammation; Off pump coronary artery bypass; Propofol; Reperfusion injury; Sevoflurane

Indexed keywords

ISOPROSTANE DERIVATIVE; NITRATE; NITRITE; PROPOFOL; SEVOFLURANE;

ADULT; ANAEROBIC METABOLISM; ANASTOMOSIS; ANTIOXIDANT ACTIVITY; ARTICLE; BLOOD SAMPLING; CANNULA; CLINICAL ARTICLE; CONTROLLED STUDY; CORONARY SINUS BLOOD FLOW; DISEASE MARKER; FEMALE; HEART MUSCLE ISCHEMIA; HEART MUSCLE REVASCULARIZATION; HEART PROTECTION; HUMAN; LABORATORY TEST; LIPID PEROXIDATION; MALE; NITROSATIVE STRESS; OFF PUMP CORONARY SURGERY; OXIDATIVE STRESS; POSTOPERATIVE CARE; RANDOMIZED CONTROLLED TRIAL; REPERFUSION INJURY; SINGLE BLIND PROCEDURE;

AGED; ANTIOXIDANTS; CARDIOTONIC AGENTS; CORONARY ARTERY BYPASS, OFF-PUMP; FEMALE; HUMANS; LIPID PEROXIDATION; MALE; METHYL ETHERS; MIDDLE AGED; MYOCARDIUM; OXIDATIVE STRESS; PROPOFOL; PROSPECTIVE STUDIES; SINGLE-BLIND METHOD;

EID: 84856453332     PISSN: 02650215     EISSN: 13652346     Source Type: Journal    
DOI: 10.1097/EJA.0b013e32834bea2a     Document Type: Article

References (34)

1. Kevin LG, Novalija E, Stowe DF. Reactive oxygen species as mediators of cardiac injury and protection: the relevance to anaesthesia practice. Anesth Analg 2005;101:1275-1287. (Pubitemid 41531857)
2. Dhalla NS, Elmoselhi AB, Hata T, Makino N. Status of myocardial antioxidants in ischemia-reperfusion injury. Cardiovasc Res 2000;47:446-456. (Pubitemid 30646067)
3. Sakamoto H, Corcoran TB, Laffey JG, Shorten GD. Isoprostanes: markers of ischemia reperfusion injury. Eur J Anaesthesiol 2002;19:550-559. (Pubitemid 34855557)
4. Milne GL, Sanchez SC, Musiek ES, Morrow JD. Quantification of F2-isoprostanes as a biomarker of oxidative stress. Nat Protoc 2007;2:221-226. (Pubitemid 47040087)
5. Liu W, Morrow JD, Yin H. Quantification of F2-isoprostanes as a reliable index of oxidative stress in vivo using gas chromatography-mass spectrometry (GC-MS) method. Free Radic Biol Med 2009;47:1101-1107.
6. Ansley DM, Xia Z, Dhaliwal BS. The relationship between plasma free 15-F2t-isoprostane concentration and early postoperative cardiac depression following warm heart surgery. J Thorac Cardiovasc Surg 2003;126:1222-1223. (Pubitemid 37305728)
7. Tsikas D. A critical review and discussion of analytical methods in the L-arginine/nitric oxide area of basic and clinical research. Anal Biochem 2008;379:139-163.
8. Zhang SH, Wang SY, Yao SL. Antioxidative effect of propofol during cardiopulmonary bypass in adults. Acta Pharmacol Sin 2004;25:334-340.
9. Javadov SA, Lim K H H, Kerr PM, et al. Protection of hearts from reperfusion injury by propofol is associated with inhibition of the mitochondrial permeability transition. Cardiovasc Res 2000;45:360-369. (Pubitemid 30069501)
10. Sayin MM, Ozatamer O, Taşöz R, et al. Propofol attenuates myocardial lipid peroxidation during coronary artery bypass grafting surgery. Br J Anaesth 2002;89:242-246.
11. Xia Z, Huang Z, Ansley DM. Large-dose propofol during cardiopulmonary bypass decreases biochemical markers of myocardial injury in coronary surgery patients: a comparison with isoflurane. Anesth Analg 2006;103:527-532. (Pubitemid 44542898)
12. Corcoran TB, Engel A, Sakamoto H, et al. The effects of propofol on neutrophil function, lipid peroxidation and inflammatory response during elective coronary artery bypass grafting in patients with impaired ventricular function. Br J Anaesth 2006;97:825-831. (Pubitemid 44823668)
13. Kevin LG, Novalija E, Riess ML, et al. Sevoflurane exposure generates superoxide but leads to decreased superoxide during ischemia and reperfusion in isolated hearts. Anesth Analg 2003;96:949-955. (Pubitemid 36359021)
14. De Hert SG, Van der Linden PJ, Cromheecke S, et al. Cardioprotective properties of sevoflurane in patients undergoing coronary surgery with cardiopulmonary bypass are related to the modalities of its administration. Anesthesiology 2004;101:299-310. (Pubitemid 38988484)
15. Yu CH, Beattie WS. The effects of volatile anesthetics on cardiac ischemic complications and mortality in CABG: a meta-analysis. Can J Anaesth 2006;53:906-918. (Pubitemid 44696515)
16. Symons JA, Myles PS. Myocardial protection with volatile anaesthetic agents during coronary artery bypass surgery: a meta-analysis. Br J Anaesth 2006;97:127-136. (Pubitemid 44295694)
17. Bein B, Renner J, Caliebe D, et al. The effects of interrupted or continuous administration of sevoflurane on preconditioning before cardio-pulmonary bypass in coronary artery surgery: comparison with continuous propofol. Anaesthesia 2008;63:1046-1055.
18. Tritapepe L, Landoni G, Guarracino F, et al. Cardiac protection by volatile anaesthetics: a multicentre randomized controlled study in patients undergoing coronary artery bypass grafting with cardiopulmonary bypass. Eur J Anaesthesiol 2007;24:323-331.
19. Van Boven WJ, Gerritsen WB, Driessen AH, et al. Myocardial oxidative stress, and cell injury comparing three different techniques for coronary artery bypass grafting. Eur J Cardiothorac Surg 2008;34:969-975.
20. Conzen PF, Fischer S, Detter C, Peter K. Sevoflurane provides greater protection of the myocardium than propofol in patients undergoing off-pump coronary artery bypass surgery. Anesthesiology 2003;99:826-833. (Pubitemid 37186071)
21. Drenger B, Gilon D, Chevion M, et al. Myocardial metabolism altered by ischemic preconditioning and enflurane in off-pump coronary artery surgery. J Cardiothorac Vasc Anesth 2008;22:369-376.
22. Johansen JW, Sebel PS. Development and clinical application of electroencephalographic bispectrum monitoring. Anesthesiology 2000;93:1336-1344.
23. Lerman J. Study design in clinical research: sample size estimation and power analysis. Can J Anaesth 1996;43:184-191. (Pubitemid 26111481)
24. Kijima Y, Hashimura K, Matsu-ura Y, et al. Transcardiac 8-iso-prostaglandin F2 (generation from acute myocardial infarction heart: insight into abrupt reperfusion and oxidant stress. Prostaglandins Leukot Essent Fatty Acids 2001;64:161-166. (Pubitemid 32896816)
25. Iuliano L, Praticò D, Greco C, et al. Angioplasty increases coronary sinus F2-isoprostane formation: evidence for in vivo oxidative stress during PTCA. J Am Coll Cardiol 2001;37:76-80. (Pubitemid 32051721)
26. Lucchinetti E, Hofer C, Bestmann L, et al. Gene regulatory control of myocardial energy metabolism predicts postoperative cardiac function in patients undergoing off-pump coronary artery bypass graft surgery: inhalational versus intravenous anesthetics. Anesthesiology 2007;106:444-457. (Pubitemid 46662209)
27. Lucchinetti E, Wang L, Ko K W S, et al. Enhanced glucose uptake via GLUT4 fuels recovery from calcium overload after ischaemia-reperfusion injury in sevoflurane-but not propofol-treated hearts. Br J Anaesth 2011;106:792-800.
28. Müllenheim J, Ebel D, Frä ssdorf J, et al. Isoflurane preconditions myocardium against infarction via release of free radicals. Anesthesiology 2002;96:934-940. (Pubitemid 34266688)
29. Wang L, Ko K W S, Lucchinetti E, et al. Metabolic Profiling of hearts exposed to sevoflurane and propofol reveals distinct regulation of fatty acid and glucose oxidation: CD36 and pyruvate dehydrogenase as key regulators in anesthetic-induced fuel shift. Anesthesiology 2010;113:541-551.
30. Yildirim V, Doganci S, Aydin A, et al. Cardioprotective effects of sevoflurane, isoflurane and propofol in coronary surgery patients: a randomized controlled study. Heart Surg Forum 2009;12:E1-E9.
31. Zhong C, Zhou Y, Liu H. Nuclear factor kappaB and anesthetic preconditioning during myocardial ischemia-reperfusion. Anesthesiology 2004;11:540-546. (Pubitemid 38268870)
32. González-Correa JA, Cruz-Andreotti E, Arrebola MM, et al. Effects of propofol on the leukocyte nitric oxide pathway: in vitro and ex vivo studies in surgical patients. Naunnyn-Schmiedeberg's Arch Pharmacol 2008;376:331-339.
33. Law-Koune JD, Raynaud C, Liu N, et al. Sevoflurane-remifentanil versus propofol-remifentanil anaesthesia at a similar bispectral level for off-pump coronary artery surgery: no evidence of reduced myocardial ischemia.
34. J Cardiothorac Vasc Anesth 2006;20:484-492.